title: Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changes.
abstract: Infection of primates by yellow fever virus (YFV) often results in severe multi-organ failure with marked histologic abnormalities. However, the role of host's immune response, particularly innate immunity, in disease process is unclear. In this study, we used a well established hamster model of yellow fever to examine the dynamic changes of cytokine expression and histopathology in the liver, spleen, kidney, and heart during the course of YFV infection. We observed that the levels of inflammatory cytokines (IFN-gamma, IL-2, TNF-alpha) in the liver were significantly reduced in the mid-stage of infection (8 days), but were elevated later (12 days). In contrast, IL-12p40 was elevated throughout the infection. The levels of IFN-gamma, IL-2, and TNF-alpha were increased in the spleen, kidney, and heart throughout the study period. For regulatory cytokines, IL-10 was significantly increased, and TGF-beta was reduced in the liver, spleen and heart in both early and mid-stages of infection, but was elevated in the kidney during the entire course of infection. In view of the pathologic changes, the observed cytokine profiles suggest that YFV has immunosuppressive effects, which contribute to liver damage in the mid-stage of infection, followed by an immunopathogenic mechanism that leads to disease progression during the late-stages of infection. Our findings support the hypothesis that organ injury by YFV is probably due to a combination of multiple factors, including direct viral injury and host innate immune responses.
authors.affiliation: Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
authors.forename: Guangyu
authors.initials: G
authors.lastname: Li
authors.forename: Tao
authors.initials: T
authors.lastname: Duan
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Wu
authors.forename: Robert B
authors.initials: RB
authors.lastname: Tesh
authors.forename: Lynn
authors.initials: L
authors.lastname: Soong
authors.forename: Shu-Yuan
authors.initials: SY
authors.lastname: Xiao
references.citation: Emerg Infect Dis. 2004 Sep;10(9):1578-84
references.pmid: 15498159
references.citation: J Pathol. 1978 Jul;125(3):131-8
references.pmid: 102747
references.citation: Diabetes. 2000 Nov;49(11):1801-9
references.pmid: 11078446
references.citation: Lancet Infect Dis. 2001 Aug;1(1):11-20
references.pmid: 11871403
references.citation: J Infect Dis. 2001 May 15;183(10):1431-6
references.pmid: 11319679
references.citation: J Virol. 2001 Mar;75(5):2107-18
references.pmid: 11160715
references.citation: Crit Rev Clin Lab Sci. 2004;41(4):391-427
references.pmid: 15487593
references.citation: Rev Infect Dis. 1987 Jan-Feb;9(1):165-75
references.pmid: 3547569
references.citation: Rev Med Virol. 2001 Mar-Apr;11(2):87-101
references.pmid: 11262528
references.citation: Infect Immun. 1994 Dec;62(12):5498-504
references.pmid: 7960131
references.citation: J Med Virol. 2001 Nov;65(3):561-6
references.pmid: 11596094
references.citation: J Immunol. 1992 Feb 15;148(4):1182-7
references.pmid: 1531351
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Neurology. 1996 Aug;47(2):417-24
references.pmid: 8757014
references.citation: Am J Pathol. 1928 Sep;4(5):395-406.1
references.pmid: 19969807
references.citation: Adv Virus Res. 2003;60:343-95
references.pmid: 14689698
references.citation: Vet Immunol Immunopathol. 2001 Feb 10;78(3-4):305-15
references.pmid: 11292531
references.citation: Cell Immunol. 1995 Jul;163(2):268-79
references.pmid: 7606798
references.citation: Exp Anim. 2002 Oct;51(5):447-55
references.pmid: 12451705
references.citation: Emerg Infect Dis. 2001;7(3 Suppl):565-9
references.pmid: 11485676
references.citation: Virology. 2006 Feb 5;345(1):22-30
references.pmid: 16278000
references.citation: Clin Exp Immunol. 2001 Jun;124(3):453-60
references.pmid: 11472407
references.citation: Infect Immun. 2000 Sep;68(9):5234-40
references.pmid: 10948149
references.citation: J Virol. 2004 Mar;78(6):3162-9
references.pmid: 14990737
references.citation: Trends Immunol. 2002 Apr;23(4):194-200
references.pmid: 11923114
references.citation: Adv Virus Res. 2003;61:291-315
references.pmid: 14714435
references.citation: Annu Rev Immunol. 1995;13:251-76
references.pmid: 7612223
references.citation: J Infect Dis. 2001 May 15;183(10):1437-44
references.pmid: 11319680
references.citation: J Virol. 1984 Feb;49(2):490-6
references.pmid: 6319748
references.citation: JAMA. 1996 Oct 9;276(14):1157-62
references.pmid: 8827969
references.citation: Nature. 1986 Oct 30-Nov 5;323(6091):819-22
references.pmid: 2430188
references.citation: Am J Trop Med Hyg. 2004 Sep;71(3):306-12
references.pmid: 15381811
references.citation: Infect Immun. 1998 May;66(5):2135-42
references.pmid: 9573100